Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Keymed Biosciences, Inc.
HK$62.80
HK$15.68B
―
43.93%
4 Buy
0 Hold
0 Sell
Strong Buy
Simcere Pharmaceutical Group Limited
HK$13.09
HK$32.58B
32.51
84.63%
2 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.34
HK$10.71B
-51.15
107.78%
1 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$15.60
HK$9.65B
-16.79
53.85%
0 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$28.30
HK$12.78B
89.37
282.43%
―
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
54.55
20.00
57.89%
HK:1672
Ascletis Pharma, Inc.
14.52
12.35
569.12%
HK:2096
Simcere Pharmaceutical Group Limited
13.09
6.28
92.22%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.34
2.69
101.51%
HK:2171
CARsgen Therapeutics Holdings Ltd.
15.60
5.95
61.66%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
28.30
20.20
249.38%